Resveratrol attenuates ischemic brain damage in the delayed phase after stroke and induces messenger RNA and protein express for angiogenic factors

Journal of Vascular Surgery

Volumn 48, Issue 3, 2008, Pages 709-714

  Dong, WenPeng ^a   Li, NanLin ^a   Gao, DaKuan ^a   Zhen, HaiNing ^a   Zhang, Xiang ^a   Li, FanFan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; MESSENGER RNA; RESVERATROL; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DAMAGE; BRAIN ISCHEMIA; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NEUROLOGIC EXAMINATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM; STROKE;

ANGIOGENIC PROTEINS; ANIMALS; BLOTTING, WESTERN; BRAIN; COLORING AGENTS; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; IMMUNOHISTOCHEMISTRY; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MATRIX METALLOPROTEINASE 2; MICE; MICE, INBRED BALB C; MICROCIRCULATION; MOTOR ACTIVITY; NEOVASCULARIZATION, PHYSIOLOGIC; NEUROPROTECTIVE AGENTS; REPERFUSION INJURY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STILBENES; STROKE; TETRAZOLIUM SALTS; TIME FACTORS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 49749094366     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2008.04.007     Document Type: Article

References (23)

1. Cox A.M., McKevitt C., Rudd A.G., and Wolfe C.D. Socioeconomic status and stroke. Lancet Neurol 5 (2006) 181-188
2. World Health Organisation. World Health Report 2004 Changing History (2004), World Health Organisation, Geneva (Statistical Annex)
3. Bejot Y., Caillier M., Rouaud O., Benatru I., Maugras C., Osseby G.V., et al. Epidemiology of strokes. Impact on the treatment decision. Presse Med 36 (2007) 117-127
4. Baur J.A., and Sinclair D.A. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5 (2006) 493-506
5. Sengottuvelan M., Viswanathan P., and Nalini N. Chemopreventive effect of trans-resveratrol-a phytoalexin against colonic aberrant crypt foci and cell proliferation in 1,2-dimethylhydrazine induced colon carcinogenesis. Carcinogenesis 27 (2006) 1038-1046
6. Ahmad K.A., Harris N.H., Johnson A.D., Lindvall H.C., Wang G., and Ahmed K. Protein kinase CK2 modulates apoptosis induced by resveratrol and epigallocatechin-3-gallate in prostate cancer cells. Mol Cancer Ther 6 (2007) 1006-1012
7. Stef G., Csiszar A., Lerea K., Ungvari Z., and Veress G. Resveratrol inhibits aggregation of platelets from high-risk cardiac patients with aspirin resistance. J Cardiovasc Pharmacol 48 (2006) 1-5
8. Howitz K.T., Bitterman K.J., Cohen H.Y., Lamming D.W., Lavu S., Wood J.G., et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425 (2003) 191-196
9. Baur J.A., Pearson K.J., Price N.L., Jamieson H.A., Lerin C., Kalra A., et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444 (2006) 337-342
10. Inoue H., Jiang X.F., Katayama T., Osada S., Umesono K., and Namura S. Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferator-activated receptor alpha in mice. Neurosci Lett 352 (2003) 203-206
11. Gao D., Zhang X., Jiang X., Peng Y., Huang W., Cheng G., et al. Resveratrol reduces the elevated level of MMP-9 induced by cerebral ischemia-reperfusion in mice. Life Sci 78 (2006) 2564-2570
12. Raval A.P., Dave K.R., and Perez-Pinzon M.A. Resveratrol mimics ischemic preconditioning in the brain. J Cereb Blood Flow Metab 26 (2006) 1141-1147
13. Huang S.S., Tsai M.C., Chih C.L., Hung L.M., and Tsai S.K. Resveratrol reduction of infarct size in Long-Evans rats subjected to focal cerebral ischemia. Life Sci 69 (2001) 1057-1065
14. Sinha K., Chaudhary G., and Gupta Y.K. Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats. Life Sci 71 (2002) 655-665
15. Gao Z.B., and Hu G.Y. Trans-resveratrol, a red wine ingredient, inhibits voltage-activated potassium currents in rat hippocampal neurons. Brain Res 1056 (2005) 68-75
16. Zamin L.L., Dillenburg-Pilla P., Argenta-Comiran R., Horn A.P., Simao F., Nassif M., et al. Protective effect of resveratrol against oxygen-glucose deprivation in organotypic hippocampal slice cultures: Involvement of PI3-K pathway. Neurobiol Dis 24 (2006) 170-182
17. Wang Q., Xu J., Rottinghaus G.E., Simonyi A., Lubahn D., Sun G.Y., et al. Resveratrol protects against global cerebral ischemic injury in gerbils. Brain Res 958 (2002) 439-447
18. Kilic U., Kilic E., Dietz G.P., and Bahr M. Intravenous TAT-GDNF is protective after focal cerebral ischemia in mice. Stroke 34 (2003) 1304-1310
19. Menzies S.A., Hoff J.T., and Betz A.L. Middle cerebral artery occlusion in rats: a neurological and pathological evaluation of a reproducible model. Neurosurgery 31 (1992) 100-107
20. Tsai S.K., Hung L.M., Fu Y.T., Cheng H., Nien M.W., Liu H.Y., et al. Resveratrol neuroprotective effects during focal cerebral ischemia injury via nitric oxide mechanism in rats. J Vasc Surg 46 (2007) 346-353
21. Kaga S., Zhan L., Matsumoto M., and Maulik N. Resveratrol enhances neovascularization in the infarcted rat myocardium through the induction of thioredoxin-1, heme oxygenase-1 and vascular endothelial growth factor. J Mol Cell Cardiol 39 (2005) 813-822
22. Fukuda S., Kaga S., Zhan L., Bagchi D., Das D.K., Bertelli A., et al. Resveratrol ameliorates myocardial damage by inducing vascular endothelial growth factor-angiogenesis and tyrosine kinase receptor Flk-1. Cell Biochem Biophys 44 (2006) 43-49
23. Gu J., Wang C.Q., Fan H., Ding H., Xie X.L., Xu Y.M., et al. Effects of resveratrol on endothelial progenitor cells and their contributions to reendothelialization in intima-injured rats. J Cardiovasc Pharmacol 47 (2006) 711-721